Product
OBI-992
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
A Phase 1/2, Open-Label, Dose-Escalation and Cohort-Expansion Study Evaluating the Safety, Pharmacokinetics, and Therapeutic Activity of OBI-992 in Subjects With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2027-06-01